Liver function test and pregnancy

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 22, Issue 3, 2009, Pages 274-283

  Jamjute, Pradumna ^a   Ahmad, Amir ^a   Ghosh, Tarun ^a   Banfield, Philip ^a  

^a GLAN CLWYD HOSPITAL   (United Kingdom)

Author keywords

Liver function tests; Pregnancy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALCOHOL; ALKALINE PHOSPHATASE; AMMONIA; ANABOLIC AGENT; ANTICONVULSIVE AGENT; ASPARTATE AMINOTRANSFERASE; BILE ACID; BILIRUBIN; CERULOPLASMIN; CORTICOSTEROID; HERBACEOUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ILLICIT DRUG; LACTATE DEHYDROGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; SERUM ALBUMIN; TUBERCULOSTATIC AGENT; VITAMIN K GROUP; ALBUMINOID;

ACUTE FATTY LIVER OF PREGNANCY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER DISEASE; ALKALINE PHOSPHATASE BLOOD LEVEL; AMMONIA BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; CERULOPLASMIN BLOOD LEVEL; CHOLECYSTECTOMY; CHOLECYSTITIS; CHOLELITHIASIS; CHOLESTASIS; CHOLESTEROL BLOOD LEVEL; COMMON BILE DUCT STONE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MARKER; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; FATTY LIVER; FIRST TRIMESTER PREGNANCY; FLUID THERAPY; GALLSTONE; GENETIC PREDISPOSITION; HELLP SYNDROME; HEPATIC ENCEPHALOPATHY; HUMAN; HYPEREMESIS GRAVIDARUM; INTRAHEPATIC CHOLESTASIS; LIVER ABSCESS; LIVER BIOPSY; LIVER DISEASE; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER ISCHEMIA; LIVER NECROSIS; LIVER RUPTURE; NONALCOHOLIC FATTY LIVER; PATHOPHYSIOLOGY; PATIENT REFERRAL; PLEURA EFFUSION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; THIRD TRIMESTER PREGNANCY; VIRUS HEPATITIS; BLOOD; ENZYMOLOGY; FEMALE; LIVER; METABOLISM; PHYSIOLOGY; PREGNANCY COMPLICATION;

ALBUMINS; BILE ACIDS AND SALTS; FEMALE; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 67650489785     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050802211929     Document Type: Review

References (51)

1. Feldman M, Friedman LS, Sleisenger MH. Sleisenger & Fordtran's gastrointestinal and liver disease. 7th ed. Philadelphia, Saunders. 2002. pp 1227-1239, 1310-1311.
2. Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of haemochromatosis. Ann Intern Med 1998;129: 925-931.
3. Eriksson S, Eriksson KF, Bondesson L. Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand 1986;220:83-88.
4. Rahman TM, Wendon J. Severe hepatic dysfunction in pregnancy. Q J Med 2002;95:343-357.
5. Pratt DS, Kaplan MM. Evaluation of abnormal liver enzyme results in asymptomatic patients. N Engl J Med 2000;342: 1266-1271.
6. Helfgott SM, Karlson E, Beckman E. Misinterpretation of serum transaminase elevation in "occult" myositis. Am J Med 1993;95:447-449.
7. Sherman KE. Alanine aminotransferase in clinical practice. Arch Intern Med 1991;151:260-265.
8. Quinn PG, Johnston DE. Detection of chronic liver disease: costs and benefits. Gastroenterologist 1997;5:58-77.
9. Carter-Pokras OD, Najjar MF, Billhymer BF, Shulman IA. Alanine aminotransferase levels in Hispanics. Ethnic Dis 1993;3:176-180.
10. Manolio TA, Burke GL, Savage PJ, Jacobs DR Jr, Sidney S, Wagenknecht LE, Allman RM, Tracy RP. Sex- and racerelated differences in liver-associated serum chemistry tests in young adults in the CARDIA study. Clin Chem 1992;38: 1853-1859.
11. Salvaggio A, Periti M, Miano L, Tavanelli M, Marzorati D. Body mass index and liver enzyme activity in serum. Clin Chem 1991;37:720-723.
12. Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 1990;99:1408-1413.
13. Vajro P, Lofrano MM, Fontanella A, Fortunato G. Immunoglobulin complexed AST ("macro-AST") in an asymptomatic child with persistent hypertransaminasemia. J Pediatr Gastroenterol Nutr 1992;15:458-460.
14. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, Yokozeki K, Kobayashi K, Irie Y. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology 1995;109:1295-1300.
15. Gitlin N, Serio KM. Ischemic hepatitis: widening horizons. Am J Gastroenterol 1992;87:831-836.
16. Cohen JA, Kaplan MM. The SGOT/SGPT ratio - an indicator of alcoholic liver disease. Dig Dis Sci 1979;24:*- 835-838.
17. Diehl AM, Potter J, Boitnott J, Van Duyn MA, Herlong HF, Mezey E. Relationship between pyridoxal 50-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 1984;86:632-636.
18. Barron WM. The syndrome of pre-eclampsia. Gastroenterol Clin North Am 1992;21:851-872.
19. Roberts WE, Perry KG Jr, Woods JB, Files JC, Blake PG, Martin JN Jr. The intra-partum platelet count in patients with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome: is it predictive of later hemorrhagic complications? Am J Obstet Gynecol 1994;171:799-804.
20. Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995; 172(1 Part 1):125-129.
21. Barton JR, Riely CA, Adamec TA, Shanklin DR, Khoury AD, Sibai BM. Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1992;167:1538-1543.
22. Cameron IT, van Papendorp CL, Palmer RM, Smith SK, Moncada S. Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertens Pregnancy 1993;12:85-92.
23. de Belder A, Lees C, Martin J, Moncada S, Campbell S. Treatment of HELLP syndrome with nitric oxide donor [Letter]. Lancet 1995;345:124-125.
24. Riely CA. Hepatic disease in pregnancy. Am J Med 1994; 96(1A):18S-22S.
25. Samuels P, Cohen AW. Pregnancies complicated by liver disease and liver dysfunction. Obstet Gynecol Clin North Am 1992;19:745-763.
26. Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995;172(1 Part 1):125-129.
27. Magann EF, Perry KG Jr, Meydrech EF, Harris RL, Chauhan SP, Martin JN Jr. Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994;171:1154-1158.
28. Martin JN Jr, Files JC, Blake PG, Perry KG Jr, Morrison JC, Norman PH. Postpartum plasma exchange for atypical preeclampsia- eclampsia as HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1995;172(4 Part 1):1107-1125.
29. Kaplan MM. Acute fatty liver of pregnancy. N Engl J Med 1985;313:367-370.
30. Riely CA, Latham PS, Romero R, Duffy TP. Acute fatty liver of pregnancy. A reassessment based on observations in nine patients. Ann Intern Med 1987;106:703-706.
31. Treem WR, Rinaldo P, Hale DE, Stanley CA, Millington DS, Hyams JS, Jackson S, Turnbull DM. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Hepatology 1994:19:339-345.
32. Sims HF, Brackett JC, Powell CK, Treem WR, Hale DE, Bennett MJ, Gibson B, Shapiro S, Strauss AW. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci USA 1995;92:841-845.
33. Smoleniec JS, James DK. Gastro-intestinal crises during pregnancy. Dig Dis 1993;11:313-324.
34. Greenstein D, Henderson JM, Boyer TD. Liver hemorrhage: recurrent episodes during pregnancy complicated by preeclampsia. Gastroenterology 1994;106:1668-1671.
35. Keeffe EB, Sunderland MC, Gabourel JD. Serum g-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapy. Dig Dis Sci 1986;31:1056-1061.
36. Hosono M, Togashi K, Kawakami S, Itoh K, Fukuoka M, Kobayashi F, Mori T, Konishi J. MR demonstration of reversible periportal abnormal intensity in eclampsia. J Comput Assist Tomogr 1994;18:143-145.
37. Pratt DS, Kaplan MM. Laboratory tests. In: Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff's diseases of the liver. 8th ed, Vol.1. Philadelphia: Lippencott-Raven; 1999. pp 205-244.
38. Mendis GP, Gibberd FB, Hunt HA. Plasma activities of hepatic enzymes in patients on anticonvulsant therapy. Seizure 1993;2:319-323.
39. Glantz A, Marschall HA, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationship between bile acids and fetal complication rates. Hepatology 2004;40:467-474.
40. Whitfield JB, Pounder RE, Neale G, Moss DW. Serum gglutamyl transpeptidase activity in liver disease. Gut 1972; 13:702-708.
41. Whitehead TP, Clarke CA, Whitfield AG. Biochemical and hematological markers of alcohol intake. Lancet 1978;1: 978-981.
42. Keeffe EB, Sunderland MC, Gabourel JD. Serum g-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapy. Dig Dis Sci 1986;31:1056-1061.
43. Mendis GP, Gibberd FB, Hunt HA. Plasma activities of hepatic enzymes in patients on anticonvulsant therapy. Seizure 1993;2:319-323.
44. Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT, Germain AM. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994;170:890-895.
45. Reyes H, Simon FR. Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin Liver Dis 1993;13:289-301.
46. Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Gastroenterol Clin North Am 1992;21:905-921.
47. Basile AS, Jones EA. Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology 1997;25:1303-1305.
48. Mabie WC. Obstetric management of gastroenterologic complications of pregnancy. Gastroenterol Clin North Am 1992;21:923-935.
49. Fallon WF Jr, Newman JS, Fallon GL, Malangoni MA. The surgical management of intra-abdominal inflammatory conditions during pregnancy. Surg Clin North Am 1995;75: 15-31.
50. Baillie J, Cairns SR, Putman WS, Cotton PB. Endoscopic management of choledocholithiasis during pregnancy. Surg Gynecol Obstet 1990;171:1-4.
51. Minuk G. Canadian Association of Gastroenterology Practice Guidelines: evaluation of abnormal liver enzyme tests. Can J Gastroenterol 1998;12:417-421.